Wall Street Analysts Believe Ascendis Pharma (ASND) Could Rally 29.83%: Here's is How to Trade

Group 1 - Ascendis Pharma A/S (ASND) shares have increased by 1.1% over the past four weeks, closing at $174.75, with a mean price target of $226.88 indicating a potential upside of 29.8% [1] - The mean estimate consists of 16 short-term price targets with a standard deviation of $28.42, where the lowest estimate is $194.00 (11% increase) and the highest is $289.00 (65.4% increase) [2] - Analysts show strong agreement on ASND's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for ASND's current year has increased by 2% over the past month, with no negative revisions [12] - ASND holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement [14]